Skip to content
Search

Latest Stories

Ashok Leyland's UK subsidiary renamed as Switch Mobility

HINDUJA GROUP firm Ashok Leyland has renamed its UK subsidiary Optare as Switch Mobility as part of the plans to bring the entire electric vehicles (EV) initiatives under one entity.

The company plans to tap the growth opportunities in the global LCV and bus EV market, which will be worth $50 billion by 2030 with a growth rate of more than 25 per cent, through financial participation and strategic tie-ups.


“Optare is adopting a new identity and logo as Switch, which signals our strategic ambitions in electric and green mobility," said Ashok Leyland chairman Dheeraj Hinduja, while unveiling the new logo and name.

The company has recently delivered 30 electric, double-decker buses to Metroline in London, and is currently fulfilling orders for operators, including Tower Transit London and First York.

Optare is a leading player in electric buses in the UK with more than 150 of them currently operating successfully in the market. It was recently named OEM of the Year (bus/commercial vehicle) at the  2020 EVIEs Awards.

Vipin Sondhi, MD & CEO, Ashok Leyland, said: “Switch will be positioned to become the potential global arm of Ashok Leyland, focused on electric vehicles and green mobility solutions. It will enable us focus on the development of new electric vehicle platforms through Switch, including next-generation buses, PODs and e-LCVs, and swiftly scale up the EV business.”

Ashok Leyland's stake in Optare has been reduced to 91.63 per cent following the conversion of loans by Hinduja Automotive (UK) into equity shares.

Andrew C Palmer, chairman of Optare, said that the re-organisation will position Switch Mobility at the forefront of the commercial EV space which will benefit the entire organisation.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less